A recent systematic review that aimed to identify published resources to support decision-making related to BRCA1 and BRCA2 genetic testing in women with breast cancer found that all studies examined (n = 9) described gains in knowledge about hereditary breast cancer, but lacked a theoretical justification for why or how interventions impacted outcomes [30]. This evidence concerns the gene BRCA1 and breast carcinoma.